Body mass index, weight change, and clinical progression in mild cognitive impairment and alzheimer disease

Alzheimer Disease and Associated Disorders

Volumn 28, Issue 1, 2014, Pages 36-43

  Besser, Lilah M ^a   Gill, Dawn P ^a,c,d   Monsell, Sarah E ^a   Brenowitz, Willa ^a   Meranus, Dana H ^a   Kukull, Walter ^a   Gustafson, Deborah R ^b,e  

^a UNIVERSITY OF WASHINGTON   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

^c Lawson Health Research Institute   (United States)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

^e UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Alzheimer disease; body mass index; body weight changes; disease progression; mild cognitive impairment; weight loss

Indexed keywords

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEINS E; BODY MASS INDEX; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MILD COGNITIVE IMPAIRMENT; WEIGHT LOSS;

EID: 84894477354     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0000000000000005     Document Type: Article

References (40)

1. Brookmeyer R, Corrada MM, Curriero FC, et al. Survival following a diagnosis of Alzheimer disease. Arch Neurol. 2002;59:1764-1767.
2. Villarejo A, Benito-Leon J, Trincado R, et al. Dementiaassociated mortality at thirteen years in the NEDICES Cohort Study. J Alzheimers Dis. 2011;26:543-551.
3. Helzner EP, Luchsinger JA, Scarmeas N, et al. Contribution of vascular risk factors to the progression in Alzheimer disease. Arch Neurol. 2009;66:343-348.
4. Gillette-Guyonnet S, Nourhashemi F, Andrieu S, et al. Weight loss in Alzheimer disease. Am J Clin Nutr. 2000;71:637S-642S.
5. White H. Weight Change in Alzheimer's Disease. J Am Geriatr Soc. 1996;44:265-272.
6. Stewart R, Masaki K, Xue QL, et al. A 32-year prospective study of change in body weight and incident dementia: the Honolulu-Asia Aging Study. Arch Neurol. 2005;62:55-60.
7. Johnson DK, Wilkins CH, Morris JC. Accelerated weight loss may precede diagnosis in Alzheimer disease. Arch Neurol. 2006;63:1312-1317.
8. Buchman AS, Wilson RS, Bienias JL, et al. Change in body mass index and risk of incident Alzheimer disease. Neurology. 2005;65:892-897.
9. Fitzpatrick AL, Kuller LH, Lopez OL, et al. Midlife and latelife obesity and the risk of dementia: cardiovascular health study. Arch Neurol. 2009;66:336-342.
10. Grundman M, Corey-Bloom J, Jernigan T, et al. Low body weight in Alzheimer's disease is associated with mesial temporal cortex atrophy. Neurology. 1996;46:1585-1591.
11. Gillette Guyonnet S, Abellan Van Kan G, Alix E, et al. IANA (International Academy on Nutrition and Aging) Expert Group: weight loss and Alzheimer's disease. J Nutr Health Aging. 2007;11:38-48.
12. Soto ME, Secher M, Gillette-Guyonnet S, et al. Weight loss and rapid cognitive decline in community-dwelling patients with Alzheimer's disease. J Alzheimers Dis. 2011;28: 647-654.
13. Cronk BB, Johnson DK, Burns JM. Body mass index and cognitive decline in mild cognitive impairment. Alzheimer Dis Assoc Disord. 2010;24:126-130.e2.
14. Coley N, Andrieu S, Jaros M, et al. Suitability of the Clinical Dementia Rating-Sum of Boxes as a single primary endpoint for Alzheimer's disease trials. Alzheimers Dement. 2011;7: 602-610.
15. Beekly DL, Ramos EM, Lee WW, et al. The National Alzheimer's Coordinating Center (NACC) database: the Uniform Data Set. Alzheimer Dis Assoc Disord. 2007;21:249-258.
16. Morris JC, Weintraub S, Chui HC, et al. The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers. Alzheimer Dis Assoc Disord. 2006;20:210-216.
17. Petersen RC, Morris JC. Mild cognitive impairment as a clinical entity and treatment target. Arch Neurol. 2005;62: 1160-1163; discussion 1167.
18. DeCarli C, Mungas D, Harvey D, et al. Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia. Neurology. 2004;63:220-227.
19. Petersen RC, Aisen PS, Beckett LA, et al. Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization. Neurology. 2010;74:201-209.
20. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDSADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
21. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43:2412-2414.
22. O'Bryant SE, Waring SC, Cullum CM, et al. Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores: a Texas Alzheimer's research consortium study. Arch Neurol. 2008;65:1091-1095.
23. Deschamps V, Astier X, Ferry M, et al. Nutritional status of healthy elderly persons living in Dordogne, France, and relation with mortality and cognitive or functional decline. Eur J Clin Nutr. 2002;56:305-312.
24. Heiat A. Impact of age on definition of standards for ideal weight. Prev Cardiol. 2003;6:104-107.
25. Guerin O, Andrieu S, Schneider SM, et al. Different modes of weight loss in Alzheimer disease: a prospective study of 395 patients. Am J Clin Nutr. 2005;82:435-441.
26. Luchsinger JA, Patel B, TangMX, et al. Measures of adiposity and dementia risk in elderly persons. Arch Neurol. 2007;64:392-398.
27. Sheikh JI, Yesavage JA. Geriatric Depression Scale (GDS): Recent Evidence and Development of a Shorter Version. Clinical Gerontology: A Guide to Assessment and Intervention. NY: The Haworth Press; 1986:165-173.
28. Gustafson DR, Backman K, Waern M, et al. Adiposity indicators and dementia over 32 years in Sweden. Neurology. 2009;73:1559-1566.
29. Gustafson DR, Ba?ckman K, Joas E, et al. 37 years of body mass index and dementia: observations from the prospective population study of women in Gothenburg, Sweden. J Alzheimers Dis. 2012;28:163-171.
30. Vanhanen M, Kivipelto M, Koivisto K, et al. APOE-epsilon4 is associated with weight loss in women with AD: a populationbased study. Neurology. 2001;56:655-659.
31. Gustafson DR. Adiposity hormones and dementia. J Neurol Sci. 2010;299:30-34.
32. Kishi T, Elmquist JK. Body weight is regulated by the brain: a link between feeding and emotion. Mol Psychiatry. 2005;10:132-146.
33. Qi Y, Takahashi N, Hileman SM, et al. Adiponectin acts in the brain to decrease body weight. Nat Med. 2004;10:524-529.
34. Harvey J, Shanley LJ, O'Malley D, et al. Leptin: a potential cognitive enhancer? Biochem Soc Trans. 2005;33:1029-1032.
35. Carro EM. Therapeutic approaches of leptin in Alzheimer's disease. Recent Pat CNS Drug Discov. 2009;4:200-208.
36. Lieb W, Beiser AS, Vasan RS, et al. Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging. JAMA. 2009;302:2565-2572.
37. Claxton A, Baker LD, Wilkinson CW, et al. Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer's disease. J Alzheimers Dis. 2013;35: 789-797.
38. Ancelin ML, Ripoche E, Dupuy AM, et al. Sex differences in the associations between lipid levels and incident dementia. J Alzheimers Dis. 2013;34:519-528.
39. Saad MF, Damani S, Gingerich RL, et al. Sexual dimorphism in plasma leptin concentration. J Clin Endocrinol Metab. 1997;82:579-584.
40. Kennedy A, Gettys TW, Watson P, et al. The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. J Clin Endocrinol Metab. 1997;82:1293-1300.